Wells Fargo & Company Cytosorbents Corp Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Cytosorbents Corp stock. As of the latest transaction made, Wells Fargo & Company holds 250 shares of CTSO stock, worth $275. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 453
44.81%
Holding current value
$275
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding CTSO
# of Institutions
54Shares Held
16.3MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC2.98MShares$3.27 Million0.45% of portfolio
-
Skylands Capital, LLC2.78MShares$3.06 Million0.38% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.09MShares$2.3 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.14 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.78MShares$1.96 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $47.9M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...